Related Experiment Videos
Divalent cobalt as a label to study lymphocyte distribution using PET and SPECT
J Korf1, L Veenma-van der Duin, R Brinkman-Medema
1Department of Biological Psychiatry, Groningen School of Behaviour and Cognitive Neurosciences, The Netherlands.
Summary
Divalent cobalt isotopes show promise for labeling lymphocytes for medical imaging. Cobalt-labeled lymphocytes demonstrated stable radioactivity in vitro and distinct biodistribution in vivo, warranting further study for human applications.
Area of Science:
- Nuclear medicine
- Cellular biology
- Biomedical imaging
Background:
- Positron Emission Tomography (PET) and Single-Photon Emission Computed Tomography (SPECT) enable in vivo lymphocyte tracking.
- Effective lymphocyte labeling requires non-toxic methods with long-term radioactivity retention (≥24 hr).
Purpose of the Study:
- To evaluate the potential of divalent cobalt isotopes (55Co2+ for PET, 57Co2+ for SPECT) for ex vivo lymphocyte labeling.
- To assess cobalt's toxicity, labeling efficiency, and in vivo biodistribution of labeled lymphocytes.
Main Methods:
- Rat lymphocytes were incubated with 57CoCl2, with toxicity assessed via trypan blue exclusion and proliferation assays.
- Biodistribution of cobalt-labeled lymphocytes was compared to free tracer using postmortem analysis.
- Cobalt uptake and binding were compared to calcium (Ca2+) in lymphocytes.
Main Results:
- Cobalt was non-cytotoxic at labeling concentrations and showed minimal radioactivity loss (<50%) over 24 hr in vitro.
- In vivo, cobalt-labeled lymphocytes exhibited unique biodistribution patterns in spleen and lungs compared to free cobalt.
- Cobalt uptake and binding by lymphocytes mimicked calcium but were stronger and nonsaturable.
Conclusions:
- Divalent cobalt isotopes are a viable option for labeling lymphocytes for PET and SPECT imaging.
- Further research is recommended to explore cobalt isotopes for human lymphocyte labeling in medical imaging applications.